adenine has been researched along with Emesis in 5 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "In a phase II study, 32 patients with advanced breast cancer previously unexposed to palliative cytotoxic chemotherapy were treated with amonafide, 800-900 mg intravenously over 3 h repeated every 4 weeks." | 9.07 | Amonafide as first-line chemotherapy for metastatic breast cancer. ( Depisch, D; Dittrich, C; Fazeny, B; Haider, K; Kornek, G; Raderer, M; Scheithauer, W, 1994) |
| "Amonafide was administered to 18 patients with advanced soft tissue sarcoma (16 of whom had received prior chemotherapy) at a dose of 300 mg/m2 over 60 min daily for 5 days." | 6.67 | Phase II evaluation of amonafide in advanced sarcoma: a Southwest Oncology Group study. ( Balcerzak, SP; Buys, SS; Metch, B; Neefe, JR; Stuckey, WJ, 1994) |
| "In a phase II study, 32 patients with advanced breast cancer previously unexposed to palliative cytotoxic chemotherapy were treated with amonafide, 800-900 mg intravenously over 3 h repeated every 4 weeks." | 5.07 | Amonafide as first-line chemotherapy for metastatic breast cancer. ( Depisch, D; Dittrich, C; Fazeny, B; Haider, K; Kornek, G; Raderer, M; Scheithauer, W, 1994) |
| "Amonafide was administered to 18 patients with advanced soft tissue sarcoma (16 of whom had received prior chemotherapy) at a dose of 300 mg/m2 over 60 min daily for 5 days." | 2.67 | Phase II evaluation of amonafide in advanced sarcoma: a Southwest Oncology Group study. ( Balcerzak, SP; Buys, SS; Metch, B; Neefe, JR; Stuckey, WJ, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhou, Y | 1 |
| Lu, H | 1 |
| Yang, M | 1 |
| Xu, C | 1 |
| Isobe, Y | 2 |
| Tobe, M | 2 |
| Ogita, H | 2 |
| Kurimoto, A | 2 |
| Ogino, T | 1 |
| Kawakami, H | 1 |
| Takaku, H | 2 |
| Sajiki, H | 1 |
| Hirota, K | 1 |
| Hayashi, H | 1 |
| Hashimoto, K | 1 |
| Nakamura, T | 1 |
| Norimura, K | 1 |
| Buys, SS | 1 |
| Metch, B | 1 |
| Balcerzak, SP | 1 |
| Neefe, JR | 1 |
| Stuckey, WJ | 1 |
| Kornek, G | 1 |
| Raderer, M | 1 |
| Depisch, D | 1 |
| Haider, K | 1 |
| Fazeny, B | 1 |
| Dittrich, C | 1 |
| Scheithauer, W | 1 |
1 review available for adenine and Emesis
| Article | Year |
|---|---|
Adverse drug events associated with ibrutinib for the treatment of elderly patients with chronic lymphocytic leukemia: A systematic review and meta-analysis of randomized trials.
Topics: Abdominal Pain; Adenine; Constipation; Diarrhea; Female; Humans; Leukemia, Lymphocytic, Chronic, B-C | 2019 |
2 trials available for adenine and Emesis
| Article | Year |
|---|---|
Phase II evaluation of amonafide in advanced sarcoma: a Southwest Oncology Group study.
Topics: Adenine; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Female; Humans; Imides; | 1994 |
Amonafide as first-line chemotherapy for metastatic breast cancer.
Topics: Adenine; Adult; Aged; Agranulocytosis; Antineoplastic Agents; Breast Neoplasms; Female; Humans; Imid | 1994 |
2 other studies available for adenine and Emesis
| Article | Year |
|---|---|
Synthesis and structure-activity relationships of 2-substituted-8-hydroxyadenine derivatives as orally available interferon inducers without emetic side effects.
Topics: Adenine; Administration, Oral; Aminoquinolines; Animals; Imiquimod; Interferon Inducers; Mice; Mice, | 2003 |
Synthesis and biological evaluation of novel 9-substituted-8-hydroxyadenine derivatives as potent interferon inducers.
Topics: Adenine; Administration, Oral; Animals; Ferrets; In Vitro Techniques; Interferon Inducers; Interfero | 2006 |